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PREFACE 
This thesis is written in the style required by The American Society for Microbiology for 
the Journal of Bacteriology, to which a portion will be submitted for publication.  
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ABSTRACT 
Given the alternative functions of “antibiotics” as communication molecules or 
participants in metabolism, it seems probable that production might be influenced by 
factors such as nutrient availability, interactions with neighboring microbes, and/or 
colony or community structure and maturity.  With this in mind, the present study aimed 
to broaden the scope of the search for novel antibiotics by experimenting with the 
following parameters: source of bacterial isolation, growth and assay media, and 
culturing techniques.  Bacteria for this study were isolated from two categories of soil 
(petroleum-contaminated or uncontaminated) to compare diversity and antimicrobial 
activity.  Compared to the uncontaminated soil, isolates of the petroleum-contaminated 
soil were as diverse and antimicrobial activity was as frequent.  Antimicrobial assays 
were done on three different types of agar, including the standard Mueller-Hinton and 
two types of medium typically used for fungal growth, Yeast Peptone Dextrose (YPD) 
and Yeast Mold (YM).  Compared to results on Mueller-Hinton, much more 
antimicrobial activity was seen when using YPD and YM.  Finally, spent media assays 
were performed with pure and mixed cultures to determine if exposure to a target 
pathogen affects the production of antimicrobial substances by soil isolates.  Those 
bacteria with activity against Pseudomonas aeruginosa in perpendicular streak tests were 
grown as mixed cultures with P. aeruginosa.  In the case of Bacillus amyloliquefaciens 
and Pseudomonas marginalis, discs impregnated with concentrated spent media from 
these mixed cultures resulted in significant dose-dependent inhibition of P. aeruginosa.  
The same assay using pure cultures showed no inhibition.    
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INTRODUCTION 
Given the alternative functions of “antibiotics” as communication molecules or 
participants in metabolism1-2, it is probable that production of antibiotics might be 
influenced by nutrient availability, interactions with neighboring microbes, or colony or 
community structure and maturity.  With this in mind, this study aimed to broaden the 
scope of the search for novel antibiotics by experimenting with the following parameters: 
source of bacterial isolation, growth and assay media, and culturing techniques.  Bacteria 
for this study were isolated from two categories of soil (petroleum-contaminated or 
uncontaminated) to compare microbial diversity and antimicrobial activity.  
Antimicrobial assays were done on three different types of agar, including the standard 
Mueller-Hinton and two complex media types typically used for fungal growth.  Finally, 
spent media assays were performed with pure and mixed cultures to determine if 
exposure to a target pathogen affects the production of antimicrobial substances by soil 
isolates.      
 
The Need for Novel Antibiotics 
According to Dr. Margaret Chan, Director-General of the World Health 
Organization, in her March 2012 address, “If current trends continue unabated, the future 
is easy to predict. Some experts say we are moving back to the pre-antibiotic era. No. 
This will be a post-antibiotic era. In terms of new replacement antibiotics, the pipeline is 
virtually dry, especially for Gram-negative bacteria. The cupboard is nearly bare.”  This 
dwindling arsenal is due to the rise in prevalence of antibiotic-resistant pathogens.  While 
many bacteria are resistant to one antibiotic or one class of antibiotics, it is the existence 
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of multi-drug resistant (MDR) pathogens that raises concern.  Many clinicians are forced 
to fall back on older, more expensive, or toxic antibiotics that might require longer 
periods of treatment, while other clinicians find they have no effective treatment.  Such 
occurrences in today’s world of modern medicine are terrifying.  
The prevalence of MDR infections, especially in clinical settings, is 
extraordinary.  Klevens et al. estimated that, in 2002, approximately 1.7 million hospital 
acquired infections (HAIs) occurred in the United States; this indicates that 5% of 
hospitalized patients acquired an infection during their stay.  Of these, 198,987 resulted in 
death, primarily from pneumonia, bloodstream infections, urinary tract infections, and 
surgical infections.3  The Annual Summary of Data issued by the National Healthcare 
Safety Network (NHSN) at the Centers for Disease Control and Prevention for 2006–
2007 reports statistics about pathogens responsible for HAIs in 463 hospitals, as well as 
the prevalence of resistance in these microbes.  Ten pathogens accounted for 84% of 
these infections: coagulase-negative staphylococci (15%), Staphylococcus aureus (15%), 
Enterococcus species (12%), Candida species (11%), Escherichia coli (10%), 
Pseudomonas aeruginosa (8%), Klebsiella pneumoniae (6%), Enterobacter species (5%), 
Acinetobacter baumannii (3%), and Klebsiella oxytoca (2%).  Of the HAIs, 16% were 
MDR pathogens: methicillin-resistant S. aureus (8%), vancomycin-resistant E. faecium, 
(4%), carbapenem-resistant P. aeruginosa (2%), extended-spectrum cephalosporin-
resistant K. pneumoniae (1%), extended-spectrum cephalosporin-resistant E. coli (<1% 
each), and carbapenem-resistant A. baumannii, K. pneumoniae, K. oxytoca, and E. coli, 
(<1% each).4        
 
3 
 
The prevalence of MDR infections has many causes, most of which are well 
understood but not well managed, despite the publication of several guidelines.5-7  The 
World Health Organization (WHO) cites the following factors as driving antibiotic 
resistance: 
 Inadequate national commitment to a comprehensive and coordinated response, 
ill-defined accountability, and insufficient engagement of communities 
 Weak or absent surveillance and monitoring systems 
 Inadequate systems to ensure quality and uninterrupted supply of medicines  
 Inappropriate and irrational use of medicines, including in animal husbandry 
 Poor infection prevention and control practice  
 Depleted arsenals of diagnostics, medicines, and vaccines as well as insufficient 
research and development of new products.  
As the last point indicates, the problem of MDR infections is exacerbated outside 
of clinical settings by a lack of interest by pharmaceutical corporations in the 
development of novel antibiotics.  The estimated average cost of developing a single drug 
is $359 million.8  Drug development averages 12 years for a candidate to make it from 
laboratory testing to testing in humans, and  only one in five candidates will ultimately 
receive FDA approval.8  Given the trend in development of antibiotic resistance, 
antibiotics are generally effective for ten years or less before a newer derivation, or 
entirely new antibiotic, becomes preferable.  These factors make development of 
antidepressants and the like financially preferable, because they can be taken for longer 
periods (the better part of a lifetime versus 7-14 days in the case of antibiotics) and 
resistance is not a factor.         
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The dearth of antibiotic development that has continued has been hindered by a 
lack of understanding of the true nature of antibiotics.  The function of antibiotics in an 
environmental setting has long been clouded by the anthropocentric view that, like 
humans, bacteria use these small molecules to kill other bacteria.  Unlike bacteria, 
though, humans use antibiotics in extremely high concentrations.  Due to lower amounts 
of nutrients in the environment compared to the high amounts in culturing media, bacteria 
are thought to produce antibiotics at very low concentrations environmentally, though 
measurement in situ is difficult.1   
The difference between therapeutic and environmental concentrations is crucial in 
understanding the natural role of antibiotics.   This is due to the phenomenon of hormetic 
concentration-responses.1  The term “hormesis” in the context of antibiotics describes the 
biphasic dose response, wherein high concentrations result in inhibition of growth, but 
low concentrations result in an enhanced ability to survive.9  Mlot suggests these small 
molecules might play crucial roles in microbial metabolism.2  Alternatively, Davies 
asserts that, in light of the low concentrations produced in typical environmental settings, 
the natural role of these small molecules referred to as antibiotics is probably modulation 
of cellular transcription patterns, not antibiosis.1   These alternative functions of 
antibiotics have been slow to be elucidated, given the difficulty of applying laboratory 
models in assessing microbial community structure and interaction in situ. 
Given that production of antibiotics, for whatever purpose, requires the 
expenditure of energy by cells, it would follow that they are not produced unless 
required.  It seems probable that this requirement might be dictated by factors such as 
nutrient availability, interactions with neighboring microbes, or colony or community 
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structure and maturity.  The requirements, in turn, are dictated by the natural function of 
the molecule.  So, complementary to metagenomics, it seems that studies surrounding 
production of small molecules with the ability to inhibit microbial growth at high 
concentrations should focus on what incites production, not just what genes are 
responsible.   
This concept is important when it comes to identifying novel antibiotics.  Given 
that the natural function of molecules with antibiotic properties is not necessarily 
antibiosis and the conditions that incite their production may be complex, it is necessary 
to diversify methods for identifying novel antibiotics.  This study aims to do so by 
varying three parameters:  source of bacterial isolation, growth and assay media, and 
culturing techniques.  
 
The ESKAPE Pathogens 
The ESKAPE bacteria are a group of pathogens gaining much notoriety.  
Members of the group are Enterococcus faecium, Staphylococcus aureus, Klebsiella 
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. 
Their ubiquity both within the human body and clinical settings, resilience, and ability to 
rapidly acquire resistance to antibiotics makes them formidable adversaries. 10  Because 
they are among the major causes of nosocomial infections, these opportunistic pathogens 
deserve a closer look.    
Enterococcus is a genus of Gram-positive cocci that normally inhabits the 
intestine of most animals.  They are common transient inhabitants of the oral cavity and 
vaginal tract of humans and are easily found in the environment, presumably because of 
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fecal contamination.  They can persist in the environment for weeks because of their 
ability to tolerate a wide range of temperatures, pH, and oxygen levels.  Clinically, they 
are a leading cause of nosocomial bacteremia, surgical and catheter infection, 
endocarditis, and urinary tract infection.11-12  Enterococci cause up to 30% of nosocomial 
endocarditis and 15-20% of nosocomial urinary tract infections.13  These conditions are 
caused by two species, E. faecalis and E. faecium.  While E. faecalis tends to be more 
virulent, causing 80% of enterococcal infections, E. faecium is more prone to acquired 
antibiotic resistance.   Much of the virulence of E. faecalis is attributed to production of 
cytolysin, extracellular superoxide, and pheromone-responsive plasmid transfer; E. 
faecium lacks these virulence factors.  Both are intrinsically resistant to many antibiotics, 
narrowing the effective treatments.   Though rare in E. faecalis, resistance to ampicillin 
and vancomycin is becoming increasingly common in E faecium.11  Vancomycin-
resistant enterococci (VRE) are now considered endemic in many hospitals, because of 
the astounding increase in epidemics over the past decade.12  NHSN data show that 
56.5% of E. faecium HAIs are vancomycin resistant and 71.0% are ampicillin resistant; 
4.7% of E. faecalis infections are vancomycin resistant, and 4.1% are ampicillin 
resistant.4  Nearly all infections by MDR enterococci are preceded by regimes of 
antibiotics, often broad spectrum, that have little or no effect on enterococci, but alter the 
presence of protective normal flora.  MDR enterococcal infections, some of which are 
resistant to all standard treatments, now occur worldwide.11   
Staphylococcus aureus, perhaps the most infamous of the ESKAPE group of 
bacteria, is a Gram-positive coccus that transiently inhabits the nose of 30% of the 
population.  S. aureus has a wide variety of virulence factors including enterotoxins, 
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exfoliative toxins, superantigens, Panton-Valentine leukocidin, adhesins, and proteases, 
which occur in varying combinations depending on the strain.14  When introduced to 
other body sites, S. aureus can cause many types of infection, ranging in severity.  The 
mild end of the spectrum includes folliculitis, cellulitis, scalded skin syndrome, and 
impetigo.  Toward the middle of the spectrum are infective endocarditis and necrotizing 
pneumonia, and at the extreme end are osteomyelitis, necrotizing fasciitis, toxic shock 
syndrome, and sepsis.  Symptoms range from abscesses requiring minor medical 
treatment, to tissue death and massive lesions often resulting in amputation or death.14   
Adding to the severity of these infections is the uncanny ability of S. aureus to rapidly 
acquire resistance.14  Through a number of mechanisms, S. aureus has acquired resistance 
to penicillin, streptomycin, tetracycline, methicillin, cephalothin, gentamicin, cefotaxime, 
linezolid, and vancomycin.  All of these resistances, with the exception of vancomycin, 
developed within four years of the date of  approved drug use by the FDA.15  NHSN 
statistics show 49.2% of S. aureus HAIs associated with cases of surgical site infection 
are oxacillin resistant.4  60% to 70% of all S. aureus hospital strains are now MDR.14  
While hospital acquired methicillin-resistant S. aureus (HA-MRSA) infections are 
worrisome, the emergence of community acquired MRSA (CA-MRSA) is cause for even 
more trepidation.16  
Klebsiella pneumoniae is a Gram-negative bacillus that normally inhabits the 
human intestine, skin, and pharynx in low numbers.17  Environmentally, K. pneumoniae 
is present in soil and water.   It causes pneumonia, urinary tract infections, bacteremia, 
osteomyelitis, wound infections, and meningitis.18  Virulence factors include capsular 
serotype, hypermucoviscosity phenotype, lipopolysaccharide, siderophores, and pili.19  
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Mortality rates for K. pneumoniae infections are near 50% and up to 100% in cases of 
alcoholism or bacteremia, even with antimicrobial therapy.17 14.8% of K. pneumoniae 
HAIs associated with surgical site infection are resistant to ceftriaxone or ceftazidime, 
and 5.2% are imipenem, meropenem, or ertapenem resistant.4  Carbapenem-resistant 
strains are also becoming a major problem in neonatal units.  Extended-spectrum beta-
lactamase (ESBL)-producing K. pneumoniae strains have been reported worldwide.19  
Panresistance, that is, resistance to all antibiotics, has been also reported.17   
Acinetobacter baumannii is a Gram-negative coccobacillus.  It naturally inhabits 
water and soil but has been isolated from food and insects20 and is known to colonize 
irrigating solutions and intravenous solutions within hospitals.21  It is a significant cause 
of ventilator-associated pneumonia, urinary tract infections, and bacteremia.  Nosocomial 
infections of the skin and soft tissue, cerebrospinal fluid, and peritoneal fluid also occur.22  
Most recently, A. baumannii infections have been associated with combat wounds 
acquired in Operation Iraqi Freedom.23  It is becoming increasingly common in hospitals, 
where it often becomes endemic for long periods of time after outbreaks.20  Many of 
these outbreaks are traced to widespread environmental contamination.21  The 
pathogenicity of A. baumannii is still being elucidated, but the ability to form a biofilm, 
ability to adhere to eukaryotic cells, iron acquisition, and use of a cytotoxic outer 
membrane protein contribute to its virulence.24  The ability to survive dry, iron-deficient 
conditions, a polysaccharide capsule that prevents complement activation and might 
delay phagocytosis, and pili also contribute.20  Mortality and morbidity of A. baumannii 
infections are difficult to surmise because most patients have other preexisting 
infections.25  A. baumannii has numerous intrinsic as well as acquired resistance 
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mechanisms.  Resistance to all generations of cephalosporins, macrolides, and penicillins 
is common.26  Of the A. baumannii HAIs associated with cases of surgical site infection, 
30.6% are imipenem or meropenem  resistant.4  For many strains, only polymyxins or 
carbapenems are effective, while still others are resistant to all antimicrobial agents.26   
Pseudomonas aeruginosa is a rather ubiquitous Gram-negative bacillus.  
Environmentally, it can be found in soil, water, plants, and animals.  It can be found as 
part of the normal flora of humans on the skin (particularly moist areas) but also in the 
gastrointestinal tract and nasopharyngeal cavities of a small percent of individuals.27  P. 
aeruginosa is most notorious for causing pneumonia, urinary tract infections, surgical site 
infections, and bloodstream infections.28  Exotoxin A, exoenzyme S, many proteases, 
siderophores, and a pseudocapsule of alginate all contribute to its virulence.  It is capable 
of acquiring resistance by most known mechanisms.29  Of the HAIs associated with 
surgical site infections caused by P. aeruginosa, 15.9% are resistant to fluoroquinolones, 
11.8% to imipenem or meropenem, 7.9% to piperacillin or piperacillin-tazobactam, 7.3% 
to ceftazidime, 5.7% to cefepime, and 2.0% to amikacin.4  Resistance to colistin is less 
common but rising, due to its use as salvage therapy in cases of MDR infections.30  
Infections by pandrug-resistant P. aeruginosa strains have been reported.31 All of the 
ESKAPE pathogens are dangerous, but recent research suggests that P. aeruginosa is 
especially dangerous, accounting for 8% of all nosocomial infections.4  It is the number 
one cause of death in patients with cystic fibrosis, the second most common cause of 
nosocomial pneumonia, and has the highest mortality rate among HAIs.28        
Enterobacter is another genus of Gram-negative bacilli that commonly inhabit 
soil and water.  The two clinically relevant species are Enterobacter cloacae and E. 
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aerogenes, both of which occur in human feces.  E. cloacae is also part of the normal 
flora of human skin and the intestinal tracts of both humans and animals.32  Similar to the 
other ESKAPE members, Enterobacter spp. cause a wide variety of infections when in 
inappropriate body sites.  These infections include but are not limited to respiratory tract 
infections, skin and soft-tissue infections, urinary tract infections, endocarditis, septic 
arthritis, osteomyelitis, central nervous system infections, and ophthalmic infections.32  
Though Enterobacter spp. virulence is not fully understood, it is thought that the ability 
to adhere to and invade eukaryotic cells, aerobactin production, and serum resistance 
contribute to its pathogenicity.33  Strains resistant to β-lactams, aminoglycosides, 
fluoroquinolones, sulfonamides, and, most recently, carbapenems have been observed.  
While pan-resistant Enterobacter infections are not yet a problem, MDR infections have 
made it crucial to identify the infection before administering antibiotics.34 
 The extent of antibiotic resistance seen in the ESKAPE pathogens emphasizes the 
urgency of continued antibiotic development.  Because of the threat they pose, these 
ESKAPE bacteria, except for Acinetobacter baumannii, were used as the target 
organisms for this research.   In addition, Saccharomyces cerevisiae was used as a target 
organism, in order to gauge antimicrobial activity against fungi.  Where complexity of 
procedures required limiting the number of target organisms, Staphylococcus aureus and 
Pseudomonas aeruginosa were chosen due to the enormity of the threat they pose.      
 
Objectives 
 This study used variations on conventional methods to qualitatively characterize 
the antimicrobial activity of bacterial soil isolates.  Bacteria for this study were isolated 
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from two categories of soil to determine if the source of isolation affected the variety of 
bacteria or their antimicrobial abilities.  In addition to the standard Mueller-Hinton agar, 
two complex fungal media were used for bacterial growth and antimicrobial-production 
assays to determine if available nutrients affected the range of antimicrobial activity of 
the soil isolates.  Finally, mixed-culture techniques were used to investigate the effect of 
interspecies interaction on antimicrobial production in comparison to antimicrobial 
production seen with pure cultures.   
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MATERIALS AND METHODS 
Acquisition of Soil Bacteria 
Soil samples were obtained from 16 sites.  Nine of these sites were considered 
uncontaminated soils: three different playa lakes in milo stubble, one dry creek bed, one 
spring-fed creek bed, one active cattle pen, one inactive cattle pen, one horse pasture, and 
one ensilage pit.  These soil samples were thought to include organic content considered 
conducive to microbial growth.  Samples from seven other sites were classified as 
petroleum-contaminated because they were near oil storage tanks.  Soil samples for these 
sites were taken from within the man-made containment dikes surrounding the oil tank 
batteries.  These dikes were designed to prevent the spread of contamination from the 
batteries, as in the case of salt water overflow or leakage of crude oil during transfer.  
These petroleum-contaminated soils appeared to have little organic content thought to 
promote microbial growth, and the aroma indicated harsh chemical components 
associated with petroleum.  In addition to these seven petroleum-contaminated soil 
samples, a contaminated water sample was also taken from one site because of obvious 
petroleum content, for a total of 17 samples.  Appendix A summarizes the sites associated 
with soil isolates’ identification numbers.            
All samples were collected in sterile 50-mL screw-top plastic vials.  
Uncontaminated soil samples were taken from between 15 and 20 cm below the surface 
to prevent inclusion of microbes present directly in the humus.  Petroleum-contaminated 
soil samples were taken from directly below the surface to ensure recent contamination.  
The water sample was taken from the surface using a sterile syringe.     
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Spread Plates and Preliminary Colony Selection 
 Contrary to the typical use of Yeast Peptone Dextrose (YPD) agar for growth of 
fungal microbes, YPD was used for selection and growth of soil bacteria.  Various 
conditions were used for spread plating, because of the unknown response of bacteria to 
such a medium and the unknown microbial density in these unusual soil samples, 
particularly those that were petroleum-contaminated.  
For all locations, 0.5 g of soil were diluted 1:100, 1:1000, and 1:10,000 using 
sterile deionized water.  For each dilution, 150 µL were applied to regular nutrient-
concentration YPD (10.0 g yeast extract, 20.0 g peptone, 20.0 g dextrose, and 15.0 g 
agar) and to low nutrient (1.0 g of yeast extract, 2.0 g peptone, and 2.0 g dextrose with 
15.0 g agar) YPD agar.  A flamed L-rod was used to spread the dilute soil evenly over the 
agar.  After the liquid dried, one plate of each soil dilution and media concentration was 
incubated at 30°C and another at room temperature.  This resulted in 12 plates for each of 
the 17 sites.   
After 24 hours incubation, colonies were selected from the spread plates.  In an 
effort to obtain a variety of bacteria, colonies were selected based on uniqueness, as 
determined by colony color, shape, and margins.  Thirty-two colonies were selected from 
petroleum-contaminated soil and 27 from uncontaminated soil.  Selected colonies were 
taken from plates using a sterile inoculating loop and streaked for isolation on YPD agar.  
After 24 hours incubation at 30°C, isolated colonies were selected from each plate and 
used to inoculate 5 mL YPD broth.  Inoculated broth was incubated 24 hours at 30°C. 
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Limiting Isolates  
To reduce the number of isolates and minimize the number of duplicates, a 
preliminary test was performed on each isolate.  Each broth-grown isolate was subjected 
to a perpendicular streak test against the target organisms Pseudomonas aeruginosa, 
Staphylococcus aureus, Klebsiella pneumoniae, Enterococcus faecalis, Enterobacter 
aerogenes, and Saccharomyces cerevisiae.  For this, a single streak of the soil isolate was 
made across a plate of YPD agar, and the plate was incubated at 30°C for 24 hours.  
Then, each target organism was streaked perpendicularly to the soil isolate, with the 
streak beginning about 1 mm from the soil isolate streak.  After 24 hours incubation at 
30°C, zones of inhibition were documented as indication of antimicrobial activity by the 
soil isolate (Figure 1).   
Soil isolates with antimicrobial activity were preserved at -80°C in 15% glycerol.  
The results of this preliminary perpendicular streak test were not reliable indicators of 
antimicrobial activity because bacterial cultures were not yet confirmed as pure; this test 
was used to reduce the number of isolates that would continue the testing process.   
 
Isolation and Species Identification of Soil Isolates     
The 28 isolates with the greatest activity in the preliminary perpendicular streak 
test (as quantified by activity against the greatest number of pathogens or size of 
inhibitory zones) or activity against S. aureus were selected for identification.  For each 
of the isolates, isolation streaks were performed three consecutive times on YPD agar, 
with 24 hours incubation at 30°C between each isolation streak.  Isolated colonies were 
inoculated into 5 mL YPD broth, incubated at 30°C for 24 hours, and preserved at -80°C 
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in 15% glycerol.  The same broth cultures were also used as inoculum for the final YPD 
isolation plates that were sent to Microbial Identification Inc. (MIDI) Labs.  There, the 
first 500bp (from the 5ʹ end) of the 16S rRNA gene were sequenced using Applied 
Biosystem’s MicroSeq® 500.  The sequences were compared to the MIDI Labs and 
GenBank databases for identification on 18 May 2012.  One of the samples was not pure, 
and so was excluded from further investigation.  In this way, soil isolates were identified 
to the species level.  Full sequences of the 500bp analysis can be viewed in Appendix B.   
 
Perpendicular Streak Tests 
 Perpendicular streak tests against the same six target organisms (P. aeruginosa, S. 
aureus, K. pneumoniae, E. faecalis, E. aerogenes, and S. cerevisiae) were performed on 
YPD agar with the remaining 27 pure culture soil isolates.  A single streak of the isolate 
was made across a plate of YPD agar, and the plate was incubated at 30°C for 24 hours.  
Then, each target organism was streaked perpendicularly to the soil isolate, with the 
beginning end of the streak abutting the soil isolate.  After 24 hours incubation at 30°C, 
zones of target organism inhibition were documented as indication of antimicrobial 
activity by the soil isolate (Figure 1). 
For isolates with differing results on the preliminary perpendicular streak test, 
Gram stains were performed on both original and isolated samples, to determine whether 
the differences were due to mixed cultures caused by incomplete isolation in preliminary 
testing. Then, the same perpendicular streak test was performed on yeast mold (YM) and 
Mueller-Hinton (MH) agars, to compare the effect of growth media on antimicrobial 
activity. 
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 In addition, all soil isolates with activity against S. cerevisiae on YPD agar, were 
subjected to a perpendicular streak test against Candida albicans on YPD and YM agars.  
Inoculation, incubation, and interpretation were identical to the original perpendicular 
streak test.                 
 
Media pH Investigation 
 To determine if the inhibitory effects of the soil isolates were influenced by a 
change in media acidity, the pH was monitored for all three media types using a Denver 
Instrument UltraBASIC Benchtop pH Meter.  Before each set of measurements, the meter 
was calibrated to within a pH of ±0.02 using 4.0 and 10.0 standards.  YPD, YM, and MH 
broths were autoclaved at 121°C for 15 minutes and allowed to cool before measuring the 
initial pH.  All three types of broth were inoculated with the soil isolates, with 5 mL broth 
and 50 µL inoculum.  These were incubated at 30°C for 24 hours, and the final pH was 
measured.  Target organisms then underwent the same investigation.  The final pH 
measurements of the soil isolates were compared to the preferred pH ranges as well as the 
measured pH of the target organisms.  As a control, 5 mL of each broth type without 
inoculum were also incubated 24 hours at 30°C, and the pH was measured.     
 To determine if the inhibitory effects were influenced by the dextrose content (the 
fermentation products of which might include organic acids), agars were made using the 
individual components of YPD: 10.0 g yeast extract and 15.0 g agar, 20.0 g peptone and 
15.0 g agar, and 20.0 g dextrose and 15.0 g agar.  These agars were used to repeat the 
perpendicular streak test using the same six target organisms (Figure 1).  Growth on agar 
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containing only dextrose was extremely limited, preventing a reliable perpendicular 
streak test.    
 
Spent Media Disc Assays 
 Cultures of soil isolates and bacterial target organisms were prepared using 50 µL 
inoculum in 5 mL YPD broth, incubated 24 hours at 30°C.  Soil isolate cultures were 
vortexed, and the resuspended liquid was transferred to centrifuge tubes.  These were 
centrifuged at 4000 rpm for 10 minutes, and the liquid was decanted into clean centrifuge 
tubes.  This process was repeated two more times, with the final liquid being decanted 
into culture tubes.  The spent media was syringe filtered, using a 0.2 µm filter, into clean 
culture tubes.  From these, 25 µL of spent media from each soil isolate were applied to 
each of six sterile paper discs.  Discs were allowed to dry for two hours.  Meanwhile, the 
bacterial target organisms (P. aeruginosa, S. aureus, K. pneumoniae, E. faecalis, and E. 
aerogenes) were resuspended by vortexing, poured into centrifuge tubes, and centrifuged 
at 4000 rpm for 10 minutes.  The broth was decanted, and the pellets of cells were 
resuspended in 0.85% NaCl solution.  These were standardized to a 0.5 McFarland 
standard by using a spectrophotometer and applied to MH agar by using sterile swabs in a 
three-way streak. After the target organism lawn had dried, a dry disc from the spent 
media of each soil isolate was applied to a quadrant of the plate.  As a control, the sixth 
disc of each soil isolate was applied to MH agar that was not inoculated, to ensure that all 
bacteria cells were properly removed from the spent media.  Plates were incubated 24 
hours at 30°C, and the sizes of inhibitory zones around the discs were recorded.  Control 
discs were inspected for bacterial growth.  The same assay was performed with the spent 
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media from soil isolate cultures after 48 and 72 hours incubation, to determine if longer 
incubation would result in a higher concentration of molecules with antimicrobial activity 
produced by the soil isolate.  The same assay was performed again using spent media 
from soil isolate cultures after 72-hour incubation, but discs were applied while still 
damp; that is, without the two-hour drying period.   
 To determine if growth in the presence of a target organism encouraged 
production of antimicrobial substances, as could possibly have been the case in the 
perpendicular streak tests, the same assay was performed using spent media from mixed 
cultures.  Soil isolates that had positive results against S. aureus in the wet disc spent 
media assay or YPD perpendicular streak test, as well as those that showed activity 
against P. aeruginosa in any of the perpendicular streak tests, were selected for this 
assay.  For mixed cultures, 5 mL YPD broth were inoculated with 50 µL of the soil 
isolate and 50 µL of the target organism against which inhibition had previously been 
observed.  Discs were applied while still damp to lawns of the target organism that was 
included in the mixed culture.     
 Finally, the same spent media disc assay was performed using concentrated spent 
media from the mixed cultures that included P. aeruginosa.  Using a vacuum centrifuge, 
50, 75, 100, 125, and 150 µL aliquots of the spent media were dehydrated to a few 
microliters, resuspended to 25 µL in sterile deionized water, and applied to sterile paper 
discs.  As a control, YPD broth was concentrated and applied to discs in the same 
fashion.  Discs were applied to lawns of P. aeruginosa while still damp.  For those soil 
isolates with positive results in this assay, the same assay was performed using 
concentrated spent media from pure cultures.      
 
19 
 
RESULTS AND DISCUSSION 
Species Identification of Soil Isolates     
Based on the sequences of the first 500bp (from the 5ʹ end) of the 16S rRNA gene 
provided by MIDI Labs, the petroleum-contaminated soil yielded 10 different species 
from 17 isolates, while the uncontaminated soil yielded 6 species from 10 isolates (Table 
1).  Appendix B contains full 500bp genetic sequences.  Because only a third of the entire 
16S rRNA gene was used and because the MIDI database is not all-inclusive, it is 
possible that the identifications were not entirely accurate.35  Sequencing the entire 16S 
rRNA gene and including other databases in the identification process could solve this 
problem. 
The petroleum-contaminated soil had three species of Bacillus (B. 
amyloliquefaciens, B. cereus, and B. subtilis) and three species of Pseudomonas (P. 
corrugata, P. fulva, and P. marginalis), which are both common genera of bacteria in 
soil.36  The uncontaminated soil also yielded these genera (B. amyoliquefaciens, P. 
corrugata, and P. fluorescens – F), though with less species richness.  Burkholderia 
cepacia is another common soil inhabitant that was found in both soil types.  B. cepacia 
is a Gram-negative bacillus that frequently causes complications for patients with cystic 
fibrosis.37   
Enterobacter sakazakii, more recently known as Cronobacter sakazakii,38 was 
isolated from the petroleum-contaminated soil; it has been known to inhabit crude oil, 
among other environmental sources.39  E. sakazakii is medically relevant for its role as a 
rare cause of invasive infection in neonates.40   Petroleum-contaminated soil also yielded 
a species of Enterococcus equally related to E. durans and E. faecium.  Both are common 
inhabitants of soil41 as well as part of the normal intestinal flora of both humans and 
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animals.34  To determine if the isolate was E. durans or E. faecium, a test could be done 
to determine if acid is produced from metabolism of glycerol or mannitol, for which a 
positive result would likely indicate E. faecium.  Another test which could determine the 
species is growth at 50°C, with growth indicating E. faecium.42  Klebsiella pneumoniae, 
either subspecies pneumoniae or rhinoscleromatus, was isolated from the uncontaminated 
soil.  The subspecies could be determined by performing a Simmons citrate test, where 
subspecies pneumoniae would have a positive result.43  While K. pneumoniae does inhabit 
soil and water, it should be noted that both it and  Staphylococcus epidermidis (found in 
both soil types) could have been contaminants from handling.  As part of human normal 
flora, they are a constant concern for contamination in the laboratory.     
 
Perpendicular Streak Tests 
In the YPD perpendicular streak test, all of the uncontaminated soil isolates 
showed at least some degree of antimicrobial activity, and only one isolate from 
petroleum-contaminated soil (Bacillus cereus) lacked antimicrobial activity (Table 2).  
This test also indicated no significant difference in the range of antimicrobial activity 
within a species between sources, as seen with Bacillus amyloliquefaciens, Burkholderia 
cepacia, Pseudomonas corrugata, and Staphylococcus aureus.      
In the perpendicular streak tests, the general trend was an increase in the range of 
target organism inhibition from MH, to YPD, to YM (Tables 2-4).  With MH, inhibition 
was limited to Staphylococcus aureus and Klebsiella pneumoniae. Both YPD and YM 
extended the activity, showing numerous incidences of inhibition against P. aeruginosa, 
E. faecalis, E. aerogenes, and S. cerevisiae in addition to S. aureus and K. pneumoniae.  
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Results of the perpendicular streak test against Candida albicans showed nearly identical 
results on YPD and YM, with the only significant difference having been a lack of C. 
albicans inhibition on YPD by one isolate of Pseudomonas corrugata (Table 5).    
 
Media pH Investigation 
Except in a few instances, pH was not the cause of the differential inhibition seen 
among the media types (Tables 6-9).  Pseudomonas aeruginosa showed relative 
sensitivity to pH changes, and Klebsiella pneumoniae and Enterobacter sakazakii were 
prone to altering pH in YM and YPD.  The inhibition of P. aeruginosa, S. aureus, E. 
faecalis, and E. aerogenes on YPD and YM by K. pneumoniae was probably not due to 
the production of an antibiotic, but rather a result of pH change caused by K. 
pneumoniae.  The inhibition of P. aeruginosa on YM by E. sakazakii might or might not 
have been due to production of an antibiotic.  Because the same inhibition was seen on 
YPD where pH was not responsible, further investigation is required to determine 
definitively whether or not E. sakazakii produces a substance that inhibits the growth of 
P. aeruginosa.   
Based on the single-component-agar perpendicular streak tests, it appeared that 
yeast extract had slightly more effect on inhibitory activity than did peptones (Tables 10-
11); however, the most inhibition was seen using complete YPD agar (Table 2).  In fact, 
Staphylococcus epidermidis, Enterobacter sakazakii, Pseudomonas marginalis, and 
Klebsiella pneumoniae seemed to require the dextrose component to encourage their full 
range of inhibitory activity.  There were exceptions however: Bacillus cereus and B. 
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subtilis had more inhibitory activity in the absence of dextrose, and B. amyloliquefaciens 
and P. fluorescens –F had equal ranges of inhibition with or without dextrose.   
 
Spent Media Disc Assays 
The pure culture spent media dry disc assays indicated no inhibition of any target 
organisms (Table 12); however, when the discs were left damp, Staphylococcus aureus 
was inhibited, to varying degrees, by spent media of the following isolates: Pseudomonas 
fluorescens-F, P. corrugata, Bacillus cereus, B. subtilis, Enterobacter sakazakii, and 
Klebsiella pneumoniae (Table 13).  It is possible that, when allowed to dry, the 
antimicrobial substances in the spent media were not able to diffuse from the discs.  
Using an Oxford cup instead of the sterile discs might resolve this issue.44   When the 
same spent media damp disc assay was performed from S. aureus mixed culture spent 
media, only one isolate of P. corrugata showed inhibition against S. aureus (Table 14).  
In instances where inhibition was seen in pure cultures but not mixed cultures, it is 
possible that in mixed cultures an antimicrobial substance was not produced, was used 
up, or that S. aureus effectively neutralized the substance.   
While no inhibition against P. aeruginosa was seen in the pure culture spent 
media dry or damp disc assays (Tables 12-13), there was inhibition by three soil isolate 
species in the mixed culture version of the assay: Bacillus amyloliquefaciens, 
Burholderia cepacia, and Pseudomonas marginalis (Table 15).  This might indicate that 
the soil bacteria produced substances in both situations but at inhibitory levels only in the 
mixed culture, or that the substances were produced only in response to being grown in 
the mixed culture.  Either way, the dose-dependent response seen from the spent media of 
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B. amyloliquefaciens and P. marginalis in the concentrated spent media assay (Table 16 
and Figure 2) suggested the substances produced by these species had antimicrobial 
effects against P. aeruginosa.    
The mixed culture version of the spent media damp disc assay showed increased 
inhibition when using Pseudomonas aeruginosa but decreased inhibition when using 
Staphylococcus aureus, in comparison to the pure culture version of these assays.  This 
phenomenon has many possible explanations.  One possibility is that, in the case of S. 
aureus, the molecules produced in pure cultures that caused antibiosis were not produced 
in the mixed cultures.  This would suggest that the molecules were not produced for the 
purpose of protection against S. aureus.  It would also imply that the molecules produced 
in pure culture that were inhibitory against P. aeruginosa were for the purpose of 
protection and were upregulated in its presence.  Another possibility is that antibiotic 
production by the soil isolates occurred in both pure and mixed cultures for both target 
organisms, but that S. aureus was more effective at neutralizing the substances than was 
P. aeruginosa.  Further testing would be necessary to determine the exact cause of the 
differential effectiveness of using mixed cultures to encourage antibiotic production.   
The chemical nature of the antimicrobial substance may also have affected all 
versions of the spent media disc assays.  If the active molecule possessed a polarity not 
complementary to medium, it may have been attracted to the cells during centrifugation 
and pulled out of the medium or attracted to the paper disc and not allowed to diffuse.  
Also, if the compound was volatile, it may have evaporated out of the disc.  A low 
molecular concentration of the antimicrobial substance would exacerbate these issues.   
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The antibiosis seen by P. corrugata and P. marginalis is typical.  Pseudomonads, 
especially the fluorescent varieties, are known for production of a wide range of 
antifungals45-46, antibiotics47-51, and organic volatiles52.  Most testing with Pseudomonads 
has centered on their use as biocontrol agents in agriculture, and testing against human 
pathogens has been limited.  While the antibiotic activity seen might be an extension in 
the spectrum of an already-documented molecule, it is also possible that there was a 
novel antibiotic involved.  To determine this, the active compound would need to be 
isolated, identified, and tested in its pure form.  This seems a worthy endeavor, 
considering the possible implications in clinical settings.   
The antibiosis seen by B. amyloliquefaciens is also typical.  Its antifungal44 and 
antibiotic53 properties are well documented.  Again, most studies surrounding 
antimicrobial production by B. amyloliquefaciens center on biocontrol in agriculture.  
One study by Nastro et al., though, produced similar results to this study, in 
demonstrating the direct inhibition of P. aeruginosa by growth of B. amyloliquefaciens 
on Tryptone Soy Agar, but not Plate Count Agar.54  While it is not clear whether it was 
the same molecule being produced in both studies, the repeatability of the phenomenon of 
P. aeruginosa inhibition by B. amyloliquefaciens makes the isolation and identification of 
the active compound a worthy endeavor. 
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CONCLUSION 
The number of species isolated from petroleum-contaminated soil indicates that 
searching for a diverse community of bacteria is practical in petroleum-contaminated soil.  
This type of soil is also a good source of antimicrobial producing bacteria, as is indicated 
by the YPD perpendicular streak test.  These results, combined with the absolute ubiquity 
of microbes, warrants study of other less orthodox soils as well.   
Given the extent of antimicrobial activity seen on YPD and YM, it can be 
concluded that complex media such as YPD and YM are viable alternatives to MH for 
this type of screening, though the effects of pH should be closely monitored.  While the 
use of complex media makes it difficult to determine exactly which ingredient is inciting 
the antimicrobial activity, the variety of components caters to a wide range of bacteria.  
This comprehensive approach is appropriate for early stages of screening and might be 
preferable as a complement to metagenomic studies.        
The increased inhibition of Pseudomonas aeruginosa by Bacillus 
amyloliquefaciens and Pseudomonas marginalis in the mixed culture spent media assay 
versus the pure culture version merits further investigation of the mixed culture approach.  
The dose-dependent response seen with the concentrated spent media of B. 
amyloliquefaciens and P. marginalis, along with their notoriety as antimicrobial-
producers, warrants isolation and identification of the compound(s) that inhibited P. 
aeruginosa in this study.  Given that all three bacteria that had success in the mixed 
culture spent media assay (B. amyloliquefaciens, P. marginalis, and P. corrugata) are 
used as biocontrol agents, it would also seem prudent to test other agricultural biocontrol 
agents against human pathogens.                      
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Diversification of the methods used to identify new antibiotics produced by 
environmental bacteria seems a valuable enterprise.  The bacteria isolated from 
petroleum-laced hypersaline soil showed great diversity and extensive antimicrobial 
activity.  The increased antimicrobial activity seen when using the YPD and YM 
encourages use of other complex media, with the caution that pH might become an issue 
with certain isolates and pathogens.  Culturing methods that encourage microbial 
interaction, such as the mixed culturing used with the spent media disc assay, should be 
employed to encourage production of molecules with unknown natural functions which, 
at high concentrations, cause antibiosis.  Finally, concentrated spent media assays should 
be used in order to identify antibiotic molecules that may be naturally produced at 
subinhibitory levels.   
Ultimately, though, it must be acknowledged that antibiotics are not a cure-all.  
While antibiotics will likely always be necessary in treating mild to moderate infections 
and in use for combination therapies, the inevitability of antibiotic resistance, especially 
with certain pathogens, necessitates the exploration of other solutions.  One of the most 
obvious solutions is to prevent infection in the first place, by continual improvement of 
sanitation and infection containment methods, especially within hospitals.  Use of 
ultraviolet radiation and novel sanitation chemicals is helpful.55-56  Upon infection, there 
is an increasing number of alternatives to simple antibiotic therapy. Immunotherapy, or 
treatment of disease by inducing, enhancing, or suppressing an immune response, is an 
alternative that shows promise in treating many robust infections, such as MRSA .57  
Another option is gene therapy, which can be used to genetically reprogram cells to 
protect themselves, as with the use in HIV/AIDs and Hepatitis B virus infections.58-59  It 
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is important to employ these complementary treatments, rather than exclusively targeting 
the pathogens with antibiotics.   
Antibiotic resistance is controllable, and yet frighteningly unavoidable.  Even 
with complementary treatments, we must maintain the antibiotic pipeline in order to 
sustain the benefits we currently receive from them.  The fate of mankind as we know it 
is dependent on continued discovery and development of novel antibiotics.   
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Table 1.  Identification of soil isolates based on the first 500 bp at the 5ʹ end of the 
genetic sequence for the 16S rRNA.  Isolates 14AS and 14AR were separated during 
isolation, but were derived from the same original culture.  For all other cultures that 
were originally mixed, a single colony type was selected and isolated.  Isolate 17D was a 
mixed culture and, so, was eliminated from further testing.   
Petroleum-Contaminated Soil Uncontaminated Soil 
Isolate 
ID Species 
Isolate 
ID Species 
11B Bacillus amyloliquefaciens 9B Bacillus amyloliquefaciens 
12B Bacillus amyloliquefaciens 9A Bacillus amyloliquefaciens 
14B Bacillus amyloliquefaciens 6C Burkholderia cepacia 
14AR Bacillus amyloliquefaciens 3B Klebsiella pneumoniae 
15C Bacillus amyloliquefaciens 5C Klebsiella pneumoniae 
13A Bacillus cereus 4B Pseudomonas corrugata 
17B Bacillus subtilis 4A Pseudomonas fluorescens-F 
10I Burkholderia cepacia 1A Staphylococcus epidermidis 
16B Enterobacter sakazakii 1C Staphylococcus epidermidis 
10B Enterococcus durans/faecium 3C Staphylococcus epidermidis 
10C Pseudomonas corrugata     
16A Pseudomonas corrugata     
14AS Pseudomonas fulva     
16C Pseudomonas marginalis     
10D Staphylococcus epidermidis     
10J Staphylococcus epidermidis     
10K Staphylococcus epidermidis     
17D mixed     
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Table 2.  Perpendicular streak test on YPD agar.  “Minor” indicates a zone of inhibition 
<5 mm, while a (+) indicates inhibition ≥5 mm.  Cells shaded gray correspond to results 
of soil isolates originating from uncontaminated soil.  Isolates are arranged in 
alphabetical order of their species ID, which can be found in Table 1.          
Isolate ID *P.a. S.a. K.p. E.f. E.a. S.c. 
11B + +   minor minor   
12B minor +   minor minor   
14B + +   minor minor   
14AR + +   minor     
15C minor +     minor   
9B + +   + +   
9A + +   minor     
13A             
17B   +         
10I minor +   minor minor + 
6C minor +   minor   + 
16B + minor + minor +   
10B minor   + minor     
3B + + + + +   
5C + + + + +   
10C + + + minor   minor 
16A   +       + 
4B + + +       
4A minor + +       
14AS + + +       
16C minor minor +       
10D + + + + +   
10J + + + + +   
10K + + + + +   
1A + + + + +   
1C + + + + +   
3C + + + + +   
 
*P.a. = Pseudomonas aeruginosa, S.a.= Staphylococcus aureus, K.p. = Klebsiella 
pneumoniae, E.f. = Enterococcus faecalis, E.a. = Enterobacter aerogenes, S.c. = 
Saccharomyces cerevisiae  
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Table 3.  Perpendicular streak test on YM agar.  “Minor” indicates a zone of inhibition 
<5 mm, while a (+) indicates inhibition ≥5 mm.  Cells shaded gray correspond to results 
of soil isolates originating from uncontaminated soil.  Isolates are arranged in order of 
their species ID, which can be found in Table 1.  Refer to Table 2 for an explanation of 
target organism abbreviations.   
Isolate ID P.a. S.a. K.p. E.f. E.a. S.c. 
11B minor + minor + + + 
12B   + + + + + 
14B minor + + + + + 
14AR + + + + + + 
15C   + + + + + 
9B + + + + + + 
9A + + + + + + 
13A             
17B   + + + + + 
10I + + + + + + 
6C + + + + + + 
16B +     minor     
10B     minor       
3B + minor + + +   
5C + minor + + +   
10C + + + + +   
16A +     + + + 
4B + + + + +   
4A   + +     + 
14AS + + + + +   
16C + + + + +   
10D + + + + +   
10J + + + + +   
10K + + + + +   
1A + + + + +   
1C + + + + +   
3C + + + + +   
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Table 4.  Perpendicular streak test on MH agar.   A (+) indicates inhibition ≥5 mm.  Cells 
shaded gray correspond to results of soil isolates originating from uncontaminated soil.  
No results exist for Saccharomyces cerevisiae because it does not grow well on MH agar.  
Isolates are arranged in order of their species ID, which can be found in Table 1.  Refer to 
Table 2 for an explanation of target organism abbreviations.             
Isolate ID P.a. S.a. K.p. E.f. E.a. 
11B   +       
12B   +       
14B   +       
14AR   +       
15C   +       
9B   +       
9A   +       
13A   +       
17B   +       
10I           
6C           
16B           
10B           
3B           
5C           
10C   + +     
16A   +       
4B   + +     
4A   +       
14AS   +       
16C   +       
10D           
10J           
10K           
1A           
1C           
3C           
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Table 5.  Perpendicular streak test against Candida albicans performed on YPD and YM 
agars.  “Minor” indicates a zone of inhibition <5 mm, while a (+) indicates inhibition ≥5 
mm.  Cells shaded gray correspond to results of soil isolates originating from 
uncontaminated soil.  Isolates are arranged in order of their species ID, which can be 
found in Table 1.           
Isolate ID YPD YM 
11B + + 
12B + + 
14B + + 
14AR + + 
15C + + 
9B + + 
9A + + 
17B + + 
10I + minor 
6C + + 
16A   + 
10C + + 
4B   + 
4A + + 
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 Table 6.  Comparison of media pH without inoculation.  
 
Media pH 
 
YPD YM MH 
After autoclaving 6.52 6.62 7.65 
After 24 hours refrigeration 6.65 6.65 7.69 
After 24 hours incubation 6.58 6.52 7.60 
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Table 7.  Investigation of pH using YPD broth.  “Minor” indicates a zone of inhibition 
<5 mm, while a (+) indicates inhibition ≥5 mm when the respective agar formulation was 
used in the perpendicular streak test.  Gray highlighted boxes indicate the possibility of 
inhibition seen in perpendicular streak tests being due to a change in pH caused by the 
soil isolate.  Sources for pH ranges are listed as 60-66 in the Literature Cited, respective 
to their appearance in this table.  Refer to Table 2 for an explanation of target organism 
abbreviations.           
   P.a. S.a. K.p. E.f. E.a. S.c. 
  pH Range >4.5 4.5-9.3 5.0-9.0  4.5-10.0 4.4-9.0 2.6-8.5 
Isolate 
ID  
Measured 
pH 7.61 5.05 4.58 4.48 5.19 5.33 
11B 6.03 + +   minor minor   
12B 6.02 minor +   minor minor   
14B 6.11 + +   minor minor   
14AR 6.08 + +   minor     
15C 5.88 minor +     minor   
9B 5.98 + +   + +   
9A 5.86 + +   minor     
13A 5.05             
17B 5.87   +         
10I 5.62 minor +   minor minor + 
6C 5.55 minor +   minor   + 
16B 4.74 + minor + minor +   
10B 7.13 minor   + minor     
3B 4.59 + + + + +   
5C 4.59 + + + + +   
10C 7.13   +       + 
16A 6.12 + + + minor   minor 
4B 6.14 + + +       
4A 6.66 minor + +       
14AS 7.21 + + +       
16C 7.30 minor minor +       
10D 7.05 + + + + +   
10J 5.02 + + + + +   
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Table 7 Continued. 
   P.a. S.a. K.p. E.f. E.a. S.c. 
  pH Range >4.5 4.5-9.3 5.0-9.0  4.5-10.0 4.4-9.0 2.6-8.5 
Isolate 
ID  
Measured 
pH 7.61 5.05 4.58 4.48 5.19 5.33 
10K 5.01 + + + + +   
1A 5.04 + + + + +   
1C 5.04 + + + + +   
3C 5.01 + + + + +   
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Table 8.  Investigation of pH using YM broth.  “Minor” indicates a zone of inhibition <5 
mm, while a (+) indicates inhibition ≥5 mm when the respective agar formulation was 
used in the perpendicular streak test.  Gray highlighted boxes indicate the possibility of 
inhibition seen in perpendicular streak tests being due to a change in pH caused by the 
soil isolate.  Sources for pH ranges are listed as 60-66 in the Literature Cited, respective 
to their appearance in this table.  Refer to Table 2 for an explanation of target organism 
abbreviations.                 
   P.a. S.a. K.p. E.f. E.a. S.c 
  pH Range >4.5 4.5-9.3 5.0-9.0  4.5-10.0 4.4-9.0 2.6-8.5 
Isolate 
ID  
Measured 
pH 7.31 4.92 4.42 4.13 4.7 5.07 
11B 5.95 minor + minor + + + 
12B 5.89   + + + + + 
14B 5.93 minor + + + + + 
14AR 5.90 + + + + + + 
15C 5.56 + + + + + + 
9B 5.80 + + + + + + 
9A 5.59   + + + + + 
13A 4.94             
17B 6.03   + + + + + 
10I 4.92 + + + + + + 
6C 4.73 + + + + + + 
16B 4.53 +     minor     
10B 6.45     minor       
3B 4.40 + minor + + +   
5C 4.41 + minor + + +   
10C 6.02 + + + + +   
16A 6.59 +     + + + 
4B 6.15 + + + + +   
4A 6.55   + +     + 
14AS 5.46 + + + + +   
16C 6.59 + + + + +   
10D 6.52 + + + + +   
10J 4.74 + + + + +   
10K 4.76 + + + + +   
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Table 8 Continued. 
   P.a. S.a. K.p. E.f. E.a. S.c 
  pH Range >4.5 4.5-9.3  5.0-9.0 4.5-10.0 4.4-9.0 2.6-8.5 
Isolate 
ID  
Measured 
pH 7.31 4.92 4.42 4.13 4.7 5.07 
1A 4.85 + + + + +   
1C 4.77 + + + + +   
3C 4.80 + + + + +   
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Table 9.  Investigation of pH using MH broth.  A (+) indicates inhibition ≥5 mm when 
the respective agar formulation was used in the perpendicular streak test.  No results are 
shown for Saccharomyces cerevisiae because it does not grow well on MH.  Sources for 
pH ranges are listed as 60-66 in the Literature Cited, respective to their appearance in this 
table.  Refer to Table 2 for an explanation of target organism abbreviations.            
   P.a. S.a. K.p. E.f. E.a. 
  pH Range >4.5 4.5-9.3 5.0-9.0  4.5-10.0 4.4-9.0 
Isolate ID  Measured pH 7.99 6.51 6.4 6.91 7.07 
11B 6.88   +       
12B 7.26   +       
14B 7.22   +       
14AR 7.18   +       
15C 7.22   +       
9B 7.29   +       
9A 6.88   +       
13A 5.88   +       
17B 7.32   +       
10I 7.63           
6C 7.69           
16B 7.19           
10B 7.88           
3B 6.75           
5C 6.71           
10C 7.84   + +     
16A 7.82   +       
4B 7.77   + +     
4A 7.77   +       
14AS 7.87   +       
16C 7.97   +       
10D 7.85           
10J 7.04           
10K 6.98           
1A 6.94           
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Table 9 Continued. 
   P.a. S.a. K.p. E.f. E.a. 
  pH Range >4.5 4.5-9.3 5.0-9.0  4.5-10.0 4.4-9.0 
Isolate ID  Measured pH 7.99 6.51 6.4 6.91 7.07 
1C 6.99      
3C 6.97      
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Table 10.  Perpendicular streak test on yeast extract agar.  “Minor” indicates a zone of 
inhibition <5 mm, while a (+) indicates inhibition ≥5 mm.  No results are shown for 
Saccharomyces cerevisiae because it does not grow well on yeast extract agar.  Refer to 
Table 2 for an explanation of target organism abbreviations.              
Isolate ID P.a. S.a. K.p. E.f. E.a. 
11B 
 
+ minor minor minor 
12B 
 
+ minor minor minor 
14B 
 
+ minor minor minor 
14AR 
 
+ minor minor minor 
15C 
 
+ minor minor minor 
9B 
 
+ minor minor minor 
9A 
 
+ + minor minor 
13A + + + + + 
17B 
 
+ + + + 
10I 
 
+ 
   6C 
 
+ 
   16B 
     10B 
 
+ 
   3B 
     5C 
     10C 
 
+ 
   16A 
 
+ 
   4B 
 
+ 
   4A 
 
+ + minor minor 
14AS 
 
+ 
   16C 
     10D 
 
+ 
   10J 
     10K 
     1A 
     1C 
     3C 
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Table 11.  Perpendicular streak test on peptones agar.  “Minor” indicates a zone of 
inhibition <5 mm, while a (+) indicates inhibition ≥5 mm.  No results are shown for 
Saccharomyces cerevisiae because it does not grow well on peptones agar.  Refer to 
Table 2 for an explanation of target organism abbreviations.              
Isolate ID  P.a. S.a. K.p. E.f. E.a. 
11B   + + minor minor 
12B   + + minor minor 
14B   + + minor minor 
14AR   + + + minor 
15C   + + + minor 
9B   + + minor minor 
9A   + + + minor 
13A   + + + + 
17B   + + + minor 
10I           
6C   minor       
16B           
10B   +       
3B           
5C           
10C   minor       
16A   minor       
4B   +       
4A   +       
14AS           
16C           
10D           
10J           
10K           
1A           
1C           
3C           
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Table 12.  Pure culture spent media dry disc assay.  A (-) indicates no inhibition against 
any of the bacterial pathogens.    
  Incubation Time (hrs) 
Isolate ID 24 48 72 
11B - - - 
12B - - - 
14AR - - - 
9B - - - 
10I - - - 
6C - - - 
14AS - - - 
4A - - - 
4B - - - 
16A - - - 
13A - - - 
17B - - - 
16B - - - 
10B - - - 
3B - - - 
5C - - - 
16C - - - 
10D - - - 
1C - - - 
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Table 13.  Pure culture spent media damp disc assay.  Numbers indicate the diameter of 
inhibitory zones, including the discs, in millimeters.  Discs are 6 mm in diameter.   A (-) 
indicates no inhibition.  Refer to Table 2 for an explanation of target organism 
abbreviations.         
Isolate ID P.a. S.a. K.p. E.f. E.a. 
11B - - - - - 
12B - - - - - 
14AR - - - - - 
9B - - - - - 
10I - - - - - 
6C - - - - - 
14AS - - - - - 
4A - 11 - - - 
4B - 11 - - - 
16A - 11 - - - 
13A - 12 - - - 
17B - 11 - - - 
16B - 11 - - - 
10B - - - - - 
3B - 11 - - - 
5C - 12 - - - 
16C - - - - - 
10D - - - - - 
1C - - - - - 
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Table 14.  Mixed culture spent media damp disc assay.   Within a column, cultures were 
grown with and tested against the target organism listed in the top row.  “NA” indicates 
that the soil isolate was not used with the target organism for the assay.  Numbers 
indicate the diameter of inhibitory zones, including the discs, in millimeters.  Discs are 6 
mm in diameter.   A (-) indicates no inhibition.     
Isolate ID P. aeruginosa S. aureus 
11B 7 - 
12B 7 - 
14AR 7.5 - 
9B 8 - 
10I 7 NA 
6C 6.5 NA 
14AS - - 
4A - - 
4B - 9 
13A NA - 
17B NA - 
16A - - 
16B - NA 
3B - NA 
5C - NA 
16C 7.5 - 
1C - NA 
10D - NA 
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Table 15.  Pseudomonas aeruginosa mixed culture concentrated spent media damp disc 
assay.  Cultures were grown with and tested against P. aeruginosa.  Numbers indicate the 
diameter of inhibitory zones, including the discs, in millimeters.  Discs are 6 mm in 
diameter.   A (-) indicates no inhibition.     
 
Volume (in µL) Concentrated to 25µL 
Isolate ID  25 50 75 100 125 150 
11B 7 11 12.5 13 15.5 17 
12B 7 11 12.5 13.5 16 19 
14AR 7.5 10 12.5 14 14 19 
9B 8 9 11 12.5 14 17 
10I 7 - - - - - 
6C 6.5 - - - - - 
14AS - - - - - - 
4A - - - - - - 
4B - - - - - - 
16A - - - - - - 
16B - - - - - - 
3B - - - - - - 
5C - - - - - - 
16C 7.5 9 14 15 16 17.5 
10D - - - - - - 
1C - - - - - - 
YPD - - 6.5 7 7 7.5 
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Table 16.  Pseudomonas aeruginosa pure culture concentrated spent media damp disc 
assay.  Cultures were tested against P. aeruginosa.  A (-) indicates no inhibition.     
 
Volume (in µL) Concentrated to 25µL 
Isolate ID  25 50 75 100 125 150 
11B - - - - - - 
12B - - - - - - 
14AR - - - - - - 
9B - - - - - - 
16C - - - - - - 
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Figure 1.  Example of a completed perpendicular streak test.  The horizontal line is the 
soil isolate streak, and the vertical lines are the target organisms.  In this example, target 
organisms (from left to right) Enterobacter aerogenes, Enterococcus faecalis, Klebsiella 
pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa are considered 
inhibited.  Saccharomyces cerevisiae (far left) is uninhibited. 
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Figure 2.  Inhibition of Pseudomonas aeruginosa in mixed culture concentrated spent 
media damp disc assay.    
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Appendix A.  Identification of soil source sites for isolates of both uncontaminated and 
petroleum-contaminated soils.  Isolation sites termed “Oil wells” refer to the soil samples 
taken from within dikes surrounding oil tank batteries.  
Isolate ID Site of Isolation 
1A-1F Playa lake 1 
2A-2B Spring-fed creek bed 
3A-3C Horse pasture 
4A-4C Inactive cattle pen 
5A-5C Ensilage pit 
6A-6B Dry creek bed 
7A-7B Playa lake 2 
8A-8B Active cattle pen 
9A-9C Playa lake 3 
10A-10K Oil well 1 
11A-11C Oil well 2 
12A-12C Oil well 3 
13A-13C Oil well 4 
14A-14B Oil well 4 water 
15A-15C Oil well 5 
16A-16C Oil well 6 
17A-17D Oil well 7 
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Appendix B. Sequences of the first 500bp at the 5ʹ end of the gene for the 16S rRNA of 
soil isolates and species identification.  
IUPAC nucleotide code interpretation66:  
A = Adenine    R = A or G B = C or G or T 
C = Cytosine Y = C or T D = A or G or T 
G = Guanine S = G or C H = A or C or T 
T = Thymine  W = A or T  V = A or C or G 
 
K = G or T  N = any base 
 
M = A or C . or - = gap 
 
1A: Staphylococcus epidermidis 
TGGAGAGTTTGATCCTGGCTCAGGATGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGAGCGAACAGACGAGGAGCTTGCTCCTCTGACGTTAGCGGC 
GGACGGGTGAGTAACACGTGGATAACCTACCTATAAGACTGGGATAACTT 
CGGGAAACCGGAGCTAATACCGGATAATATATTGAACCGCATGGTTCAAT 
AGTGAAAGACGGTTTTGCTGTCACTTATAGATGGATCCGCGCCGCATTAG 
CTAGTTGGTAAGGTAACGGCTTACCAAGGCAACGATGCGTAGCCGACCTG 
AGAGGGTGATCGGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGG 
GAGGCAGCAGTAGGGAATCTTCCGCAATGGGCGAAAGCCTGACGGAGCAA 
CGCCGCGTGAGTGATGAAGGTCTTCGGATCGTAAAACTCTGTTATTAGGG 
AAGAACAAATGTGTAAGTAACTATGCACGTCTTGACGGTACCTAATCAGA 
AAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
 
1C: Staphylococcus epidermidis 
TGGAGAGTTTGATCCTGGCTCAGGATGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGAGCGAACAGACGAGGAGCTTGCTCCTCTGACGTTAGCGGC 
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GGACGGGTGAGTAACACGTGGATAACCTACCTATAAGACTGGGATAACTT 
CGGGAAACCGGAGCTAATACCGGATAATATATTGAACCGCATGGTTCAAT 
AGTGAAAGACGGTTTTGCTGTCACTTATAGATGGATCCGCGCCGCATTAG 
CTAGTTGGTAAGGTAACGGCTTACCAAGGCAACGATGCGTAGCCGACCTG 
AGAGGGTGATCGGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGG 
GAGGCAGCAGTAGGGAATCTTCCGCAATGGGCGAAAGCCTGACGGAGCAA 
CGCCGCGTGAGTGATGAAGGTCTTCGGATCGTAAAACTCTGTTATTAGGG 
AAGAACAAATGTGTAAGTAACTATGCACGTCTTGACGGTACCTAATCAGA 
AAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
 
3B: Klebsiella pneumoniae subspecies pneumoniae or rhinoscleromatus 
TGGAGAGTTTGATCCTGGCTCAGATTGAACGCTGGCGGCAGGCCTAACAC 
ATGCAAGTCGAGCGGTAGCACAGAGAGCTTGCTCTCGGGTGACGAGCGGC 
GGACGGGTGAGTAATGTCTGGGAAACTGCCTGATGGAGGGGGATAACTAC 
TGGAAACGGTAGCTAATACCGCATAAYGTCGCAAGACCAAAGTGGGGGAC 
CTTCGGGCCTCATGCCATCAGATGTGCCCAGATGGGATTAGCTAGTAGGT 
GGGGTAACGGCTCACCTAGGCGACGATCCCTAGCTGGTCTGAGAGGATGA 
CCAGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCA 
GTGGGGAATATTGCACAATGGGCGCAAGCCTGATGCAGCCATGCCGCGTG 
TGTGAAGAAGGCCTTCGGGTTGTAAAGCACTTTCAGCGGGGAGGAAGGCG 
ATRAGGTTAATAACCTYRTCGATTGACGTTACCCGCAGAAGAAGCACCGG 
CTAACTCCGTGCCAGCAGCCGCGGTA 
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3C: Staphylococcus epidermidis 
TGGAGAGTTTGATCCTGGCTCAGGATGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGAGCGAACAGACGAGGAGCTTGCTCCTCTGACGTTAGCGGC 
GGACGGGTGAGTAACACGTGGATAACCTACCTATAAGACTGGGATAACTT 
CGGGAAACCGGAGCTAATACCGGATAATATATTGAACCGCATGGTTCAAT 
AGTGAAAGACGGTTTTGCTGTCACTTATAGATGGATCCGCGCCGCATTAG 
CTAGTTGGTAAGGTAACGGCTTACCAAGGCAACGATGCGTAGCCGACCTG 
AGAGGGTGATCGGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGG 
GAGGCAGCAGTAGGGAATCTTCCGCAATGGGCGAAAGCCTGACGGAGCAA 
CGCCGCGTGAGTGATGAAGGTCTTCGGATCGTAAAACTCTGTTATTAGGG 
AAGAACAAATGTGTAAGTAACTATGCACGTCTTGACGGTACCTAATCAGA 
AAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
 
4A: Pseudomonas fluorescens – F 
TGGAGAGTTTGATCCTGGCTCAGATTGAACGCTGGCGGCAGGCCTAACAC 
ATGCAAGTCGAGCGGCAGCACGGGTACTTGTACCTGGTGGCGAGCGGCGG 
ACGGGTGAGTAATGCCTAGGAATCTGCCTGGTAGTGGGGGATAACGCTCG 
GAAACGGACGCTAATACCGCATACGTCCTACGGGAGAAAGCAGGGGACCT 
TCGGGCCTTGCGCTATCAGATGAGCCTAGGTCGGATTAGCTAGTTGGTGA 
GGTAATGGCTCACCAAGGCGACGATCCGTAACTGGTCTGAGAGGATGATC 
AGTCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGT 
GGGGAATATTGGACAATGGGCGAAAGCCTGATCCAGCCATGCCGCGTGTG 
TGAAGAAGGTCTTCGGATTGTAAAGCACTTTAAGTTGGGAGGAAGGGCAG 
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TTACCTAATACGTATCTGTTTTGACGTTACCGACAGAATAAGCACCGGCT 
AACTCTGTGCCAGCAGCCGCGGTA 
 
4B: Pseudomonas corrugata 
TGGAGAGTTTGATCCTGGCTCAGATTGAACGCTGGCGGCAGGCCTAACAC 
ATGCAAGTCGAGCGGTAGAGAGGTGCTTGCACCTCTTGAGAGCGGCGGAC 
GGGTGAGTAATGCCTAGGAATCTGCCTGGTAGTGGGGGATAACGCTCGGA 
AACGGACGCTAATACCGCATACGTCCTACGGGAGAAAGCAGGGGACCTTC 
GGGCCTTGCGCTATCAGATGAGCCTAGGTCGGATTAGCTAGTTGGTGGGG 
TAATGGCTCACCAAGGCGACGATCCGTAACTGGTCTGAGAGGATGATCAG 
TCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGG 
GGAATATTGGACAATGGGCGAAAGCCTGATCCAGCCATGCCGCGTGTGTG 
AAGAAGGTCTTCGGATTGTAAAGCACTTTAAGTTGGGAGGAAGGGCATTA 
ACCTAATACGTTAGTGTTTTGACGTTACCGACAGAATAAGCACCGGCTAA 
CTCTGTGCCAGCAGCCGCGGTA 
 
5C: Klebsiella pneumoniae subspecies pneumoniae or rhinoscleromatus 
TGGAGAGTTTGATCCTGGCTCAGATTGAACGCTGGCGGCAGGCCTAACAC 
ATGCAAGTCGAGCGGTAGCACAGAGAGCTTGCTCTCGGGTGACGAGCGGC 
GGACGGGTGAGTAATGTCTGGGAAACTGCCTGATGGAGGGGGATAACTAC 
TGGAAACGGTAGCTAATACCGCATAAYGTCGCAAGACCAAAGTGGGGGAC 
CTTCGGGCCTCATGCCATCAGATGTGCCCAGATGGGATTAGCTAGTAGGT 
GGGGTAACGGCTCACCTAGGCGACGATCCCTAGCTGGTCTGAGAGGATGA 
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CCAGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCA 
GTGGGGAATATTGCACAATGGGCGCAAGCCTGATGCAGCCATGCCGCGTG 
TGTGAAGAAGGCCTTCGGGTTGTAAAGCACTTTCAGCGGGGAGGAAGGCG 
ATRAGGTTAATAACCTYRTCGATTGACGTTACCCGCAGAAGAAGCACCGG 
CTAACTCCGTGCCAGCAGCCGCGGTA 
 
6C: Burkholderia cepacia 
TGGAGAGTTTGATCCTGGCTCAGATTGAACGCTGGCGGCATGCCTTACAC 
ATGCAAGTCGAACGGCAGCACGGGTGCTTGCACCTGGTGGCGAGTGGCGA 
ACGGGTGAGTAATACATCGGAACATGTCCTGTAGTGGGGGATAGCCCGGC 
GAAAGCCGGATTAATACCGCATACGATCTACGGATGAAAGCGGGGGACCT 
TCGGGCCTCGCGCTATAGGGTTGGCCGATGGCTGATTAGCTAGTTGGTGG 
GGTAAAGGCCTACCAAGGCGACGATCAGTAGCTGGTCTGAGAGGACGACC 
AGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGT 
GGGGAATTTTGGACAATGGGCGAAAGCCTGATCCAGCAATGCCGCGTGTG 
TGAAGAAGGCCTTCGGGTTGTAAAGCACTTTTGTCCGGAAAGAAATCCTT 
GGCTCTAATACAGTCGGGGGATGACGGTACCGGAAGAATAAGCACCGGCT 
AACTACGTGCCAGCAGCCGCGGTA 
 
9A: Bacillus amyloliquefaciens 
TGGAGAGTTTGATCCTGGCTCAGGACGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGAGCGGACAGATGGGAGCTTGCTCCCTGATGTTAGCGGCGG 
ACGGGTGAGTAACACGTGGGTAACCTGCCTGTAAGACTGGGATAACTCCG 
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GGAAACCGGGGCTAATACCGGATGGTTGTYTGAACCGCATGGTTCAGACA 
TAAAAGGTGGCTTCGGCTACCACTTACAGATGGACCCGCGGCGCATTAGC 
TAGTTGGTGAGGTAACGGCTCACCAAGGCGACGATGCGTAGCCGACCTGA 
GAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGG 
AGGCAGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAAC 
GCCGCGTGAGTGATGAAGGTTTTCGGATCGTAAAGCTCTGTTGTTAGGGA 
AGAACAAGTGCCGTTCAAATAGGGCGGCACCTTGACGGTACCTAACCAGA 
AAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
 
9B: Bacillus amyloliquefaciens 
TGGAGAGTTTGATCCTGGCTCAGGACGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGAGCGGACAGATGGGAGCTTGCTCCCTGATGTTAGCGGCGG 
ACGGGTGAGTAACACGTGGGTAACCTGCCTGTAAGACTGGGATAACTCCG 
GGAAACCGGGGCTAATACCGGATGGTTGTYTGAACCGCATGGTTCAGACA 
TAAAAGGTGGCTTCGGCTACCACTTACAGATGGACCCGCGGCGCATTAGC 
TAGTTGGTGAGGTAACGGCTCACCAAGGCGACGATGCGTAGCCGACCTGA 
GAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGG 
AGGCAGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAAC 
GCCGCGTGAGTGATGAAGGTTTTCGGATCGTAAAGCTCTGTTGTTAGGGA 
AGAACAAGTGCCGTTCAAATAGGGCGGCACCTTGACGGTACCTAACCAGA 
AAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
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10B: Enterococcus durans or faecium 
TGGAGAGTTTGATCCTGGCTCAGGACGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGTACGCTTCTTTTTCCACCGGAGCTTGCTCCACCGGAAAAA 
GAGGAGTGGCGAACGGGTGAGTAACACGTGGGTAACCTGCCCATCAGAAG 
GGGATAACACTTGGAAACAGGTGCTAATACCGTATAACAATCGAAACCGC 
ATGGTTTTGATTTGAAAGGCGCTTTCGGGTGTCGCTGATGGATGGACCCG 
CGGTGCATTAGCTAGTTGGTGAGGTAACGGCTCACCAAGGCCACGATGCA 
TAGCCGACCTGAGAGGGTGATCGGCCACATTGGGACTGAGACACGGCCCA 
AACTCCTACGGGAGGCAGCAGTAGGGAATCTTCGGCAATGGACGAAAGTC 
TGACCGAGCAACGCCGCGTGAGTGAAGAAGGTTTTCGGATCGTAAAACTC 
TGTTGTTAGAGAAGAACAAGGATGAGAGTAACTGTTCATCCCTTGACGGT 
ATCTAACCAGAAAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
 
10C: Pseudomonas corrugata 
TGGAGAGTTTGATCCTGGCTCAGATTGAACGCTGGCGGCAGGCCTAACAC 
ATGCAAGTCGAGCGGTAGAGAGGTGCTTGCACCTCTTGAGAGCGGCGGAC 
GGGTGAGTAATGCCTAGGAATCTGCCTGGTAGTGGGGGATAACGCTCGGA 
AACGGACGCTAATACCGCATACGTCCTACGGGAGAAAGCAGGGGACCTTC 
GGGCCTTGCGCTATCAGATGAGCCTAGGTCGGATTAGCTAGTTGGTGGGG 
TAATGGCTCACCAAGGCGACGATCCGTAACTGGTCTGAGAGGATGATCAG 
TCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGG 
GGAATATTGGACAATGGGCGAAAGCCTGATCCAGCCATGCCGCGTGTGTG 
AAGAAGGTCTTCGGATTGTAAAGCACTTTAAGTTGGGAGGAAGGGCATTA 
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ACCTAATACGTTAGTGTTTTGACGTTACCGACAGAATAAGCACCGGCTAA 
CTCTGTGCCAGCAGCCGCGGTA 
 
10D: Staphylococcus epidermidis 
TGGAGAGTTTGATCCTGGCTCAGGATGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGAGCGAACAGACGAGGAGCTTGCTCCTCTGACGTTAGCGGC 
GGACGGGTGAGTAACACGTGGATAACCTACCTATAAGACTGGGATAACTT 
CGGGAAACCGGAGCTAATACCGGATAATATATTGAACCGCATGGTTCAAT 
AGTGAAAGACGGTTTTGCTGTCACTTATAGATGGATCCGCGCCGCATTAG 
CTAGTTGGTAAGGTAACGGCTTACCAAGGCAACGATGCGTAGCCGACCTG 
AGAGGGTGATCGGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGG 
GAGGCAGCAGTAGGGAATCTTCCGCAATGGGCGAAAGCCTGACGGAGCAA 
CGCCGCGTGAGTGATGAAGGTCTTCGGATCGTAAAACTCTGTTATTAGGG 
AAGAACAAATGTGTAAGTAACTATGCACGTCTTGACGGTACCTAATCAGA 
AAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
 
10I: Burkholderia cepacia 
TGGAGAGTTTGATCCTGGCTCAGATTGAACGCTGGCGGCATGCCTTACAC 
ATGCAAGTCGAACGGCAGCACGGGTGCTTGCACCTGGTGGCGAGTGGCGA 
ACGGGTGAGTAATACATCGGAACATGTCCTGTAGTGGGGGATAGCCCGGC 
GAAAGCCGGATTAATACCGCATACGATCTACGGATGAAAGCGGGGGACCT 
TCGGGCCTCGCGCTATAGGGTTGGCCGATGGCTGATTAGCTAGTTGGTGG 
GGTAAAGGCCTACCAAGGCGACGATCAGTAGCTGGTCTGAGAGGACGACC 
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AGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGT 
GGGGAATTTTGGACAATGGGCGAAAGCCTGATCCAGCAATGCCGCGTGTG 
TGAAGAAGGCCTTCGGGTTGTAAAGCACTTTTGTCCGGAAAGAAATCCTT 
GGCTCTAATACAGTCGGGGGATGACGGTACCGGAAGAATAAGCACCGGCT 
AACTACGTGCCAGCAGCCGCGGTA 
 
10J: Staphylococcus epidermidis 
TGGAGAGTTTGATCCTGGCTCAGGATGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGAGCGAACAGACGAGGAGCTTGCTCCTCTGACGTTAGCGGC 
GGACGGGTGAGTAACACGTGGATAACCTACCTATAAGACTGGGATAACTT 
CGGGAAACCGGAGCTAATACCGGATAATATATTGAACCGCATGGTTCAAT 
AGTGAAAGACGGTTTTGCTGTCACTTATAGATGGATCCGCGCCGCATTAG 
CTAGTTGGTAAGGTAACGGCTTACCAAGGCAACGATGCGTAGCCGACCTG 
AGAGGGTGATCGGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGG 
GAGGCAGCAGTAGGGAATCTTCCGCAATGGGCGAAAGCCTGACGGAGCAA 
CGCCGCGTGAGTGATGAAGGTCTTCGGATCGTAAAACTCTGTTATTAGGG 
AAGAACAAATGTGTAAGTAACTATGCACGTCTTGACGGTACCTAATCAGA 
AAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
 
10K: Staphylococcus epidermidis 
TGGAGAGTTTGATCCTGGCTCAGGATGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGAGCGAACAGACGAGGAGCTTGCTCCTCTGACGTTAGCGGC 
GGACGGGTGAGTAACACGTGGATAACCTACCTATAAGACTGGGATAACTT 
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CGGGAAACCGGAGCTAATACCGGATAATATATTGAACCGCATGGTTCAAT 
AGTGAAAGACGGTTTTGCTGTCACTTATAGATGGATCCGCGCCGCATTAG 
CTAGTTGGTAAGGTAACGGCTTACCAAGGCAACGATGCGTAGCCGACCTG 
AGAGGGTGATCGGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGG 
GAGGCAGCAGTAGGGAATCTTCCGCAATGGGCGAAAGCCTGACGGAGCAA 
CGCCGCGTGAGTGATGAAGGTCTTCGGATCGTAAAACTCTGTTATTAGGG 
AAGAACAAATGTGTAAGTAACTATGCACGTCTTGACGGTACCTAATCAGA 
AAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
 
11B: Bacillus amyloliquefaciens 
TGGAGAGTTTGATCCTGGCTCAGGACGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGAGCGGACAGATGGGAGCTTGCTCCCTGATGTTAGCGGCGG 
ACGGGTGAGTAACACGTGGGTAACCTGCCTGTAAGACTGGGATAACTCCG 
GGAAACCGGGGCTAATACCGGATGGTTGTTTGAACCGCATGGTTCAGACA 
TAAAAGGTGGCTTCGGCTACCACTTACAGATGGACCCGCGGCGCATTAGC 
TAGTTGGTGAGGTAACGGCTCACCAAGGCGACGATGCGTAGCCGACCTGA 
GAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGG 
AGGCAGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAAC 
GCCGCGTGAGTGATGAAGGTTTTCGGATCGTAAAGCTCTGTTGTTAGGGA 
AGAACAAGTGCCGTTCAAATAGGGCGGCACCTTGACGGTACCTAACCAGA 
AAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
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12B: Bacillus amyloliquefaciens 
TGGAGAGTTTGATCCTGGCTCAGGACGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGAGCGGACAGATGGGAGCTTGCTCCCTGATGTTAGCGGCGG 
ACGGGTGAGTAACACGTGGGTAACCTGCCTGTAAGACTGGGATAACTCCG 
GGAAACCGGGGCTAATACCGGATGGTTGTYTGAACCGCATGGTTCAGACA 
TAAAAGGTGGCTTCGGCTACCACTTACAGATGGACCCGCGGCGCATTAGC 
TAGTTGGTGAGGTAACGGCTCACCAAGGCGACGATGCGTAGCCGACCTGA 
GAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGG 
AGGCAGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAAC 
GCCGCGTGAGTGATGAAGGTTTTCGGATCGTAAAGCTCTGTTGTTAGGGA 
AGAACAAGTGCCGTTCAAATAGGGCGGCACCTTGACGGTACCTAACCAGA 
AAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
 
13A: Bacillus cereus 
TGGAGAGTTTGATCCTGGCTCAGGATGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGAGCGAATGGATTAAGAGCTTGCTCTTATGAAGTTAGCGGC 
GGACGGGTGAGTAACACGTGGGTAACCTGCCCATAAGACTGGGATAACTC 
CGGGAAACCGGGGCTAATACCGGATAACATTTTGAACTGCATGGTTCGAA 
ATTGAAAGGCGGCTTCGGCTGTCACTTATGGATGGACCCGCGTCGCATTA 
GCTAGTTGGTGAGGTAACGGCTCACCAAGGCAACGATGCGTAGCCGACCT 
GAGAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACG 
GGAGGCAGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCA 
ACGCCGCGTGAGTGATGAAGGCTTTCGGGTCGTAAAACTCTGTTGTTAGG 
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GAAGAACAAGTGCTAGTTGAATAAGCTGGCACCTTGACGGTACCTAACCA 
GAAAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
 
14AR: Bacillus amyloliquefaciens 
TGGAGAGTTTGATCCTGGCTCAGGACGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGAGCGGACAGATGGGAGCTTGCTCCCTGATGTTAGCGGCGG 
ACGGGTGAGTAACACGTGGGTAACCTGCCTGTAAGACTGGGATAACTCCG 
GGAAACCGGGGCTAATACCGGATGGTTGTTTGAACCGCATGGTTCAGACA 
TAAAAGGTGGCTTCGGCTACCACTTACAGATGGACCCGCGGCGCATTAGC 
TAGTTGGTGAGGTAACGGCTCACCAAGGCGACGATGCGTAGCCGACCTGA 
GAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGG 
AGGCAGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAAC 
GCCGCGTGAGTGATGAAGGTTTTCGGATCGTAAAGCTCTGTTGTTAGGGA 
AGAACAAGTGCCGTTCAAATAGGGCGGCACCTTGACGGTACCTAACCAGA 
AAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
 
14AS: Pseudomonas fulva 
TGGAGAGTTTGATCCTGGCTCAGATTGAACGCTGGCGGCAGGCCTAACAC 
ATGCAAGTCGAGCGGATGAAAGGAGCTTGCTCCTGGATTCAGCGGCGGAC 
GGGTGAGTAATGCCTAGGAATCTGCCTGGTAGTGGGGGACAACGTTTCGA 
AAGGAACGCTAATACCGCATACGTCCTACGGGAGAAAGCAGGGGACCTTC 
GGGCCTTGCGCTATCAGATGAGCCTAGGTCGGATTAGCTAGTTGGTGAGG 
TAATGGCTCACCAAGGCGACGATCCGTAACTGGTCTGAGAGGATGATCAG 
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TCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGG 
GGAATATTGGACAATGGGCGAAAGCCTGATCCAGCCATGCCGCGTGTGTG 
AAGAAGGTCTTCGGATTGTAAAGCACTTTAAGTTGGGAGGAAGGGTTGTA 
GATTAATACTCTGCAATTTTGACGTTACCGACAGAATAAGCACCGGCTAA 
CTCTGTGCCAGCAGCCGCGGTA 
 
14B: Bacillus amyloliquefaciens 
TGGAGAGTTTGATCCTGGCTCAGGACGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGAGCGGACAGATGGGAGCTTGCTCCCTGATGTTAGCGGCGG 
ACGGGTGAGTAACACGTGGGTAACCTGCCTGTAAGACTGGGATAACTCCG 
GGAAACCGGGGCTAATACCGGATGGTTGTTTGAACCGCATGGTTCAGACA 
TAAAAGGTGGCTTCGGCTACCACTTACAGATGGACCCGCGGCGCATTAGC 
TAGTTGGTGAGGTAACGGCTCACCAAGGCGACGATGCGTAGCCGACCTGA 
GAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGG 
AGGCAGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAAC 
GCCGCGTGAGTGATGAAGGTTTTCGGATCGTAAAGCTCTGTTGTTAGGGA 
AGAACAAGTGCCGTTCAAATAGGGCGGCACCTTGACGGTACCTAACCAGA 
AAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
 
15C: Bacillus amyloliquefaciens 
TGGAGAGTTTGATCCTGGCTCAGGACGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGAGCGGACAGATGGGAGCTTGCTCCCTGATGTTAGCGGCGG 
ACGGGTGAGTAACACGTGGGTAACCTGCCTGTAAGACTGGGATAACTCCG 
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GGAAACCGGGGCTAATACCGGATGGTTGTYTGAACCGCATGGTTCAGACA 
TAAAAGGTGGCTTCGGCTACCACTTACAGATGGACCCGCGGCGCATTAGC 
TAGTTGGTGAGGTAACGGCTCACCAAGGCGACGATGCGTAGCCGACCTGA 
GAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGG 
AGGCAGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAAC 
GCCGCGTGAGTGATGAAGGTTTTCGGATCGTAAAGCTCTGTTGTTAGGGA 
AGAACAAGTGCCGTTCAAATAGGGCGGCACCTTGACGGTACCTAACCAGA 
AAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
 
16A: Pseudomonas corrugata 
TGGAGAGTTTGATCCTGGCTCAGATTGAACGCTGGCGGCAGGCCTAACAC 
ATGCAAGTCGAGCGGTAGAGAGGTGCTTGCACCTCTTGAGAGCGGCGGAC 
GGGTGAGTAAAGCCTAGGAATCTGCCTGGTAGTGGGGGATAACGCTCGGA 
AACGGACGCTAATACCGCATACGTCCTACGGGAGAAAGCAGGGGACCTTC 
GGGCCTTGCGCTATCAGATGAGCCTAGGTCGGATTAGCTAGTTGGTGAGG 
TAATGGCTCACCAAGGCGACGATCCGTAACTGGTCTGAGAGGATGATCAG 
TCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGG 
GGAATATTGGACAATGGGCGAAAGCCTGATCCAGCCATGCCGCGTGTGTG 
AAGAAGGTCTTCGGATTGTAAAGCACTTTAAGTTGGGAGGAAGGGCATTA 
ACCTAATACGTTAGTGTTTTGACGTTACCGACAGAATAAGCACCGGCTAA 
CTCTGTGCCAGCAGCCGCGGTA 
 
 
 
73 
 
16B: Enterobacter sakazakii 
TGGAGAGTTTGATCCTGGCTCAGATTGAACGCTGGCGGCAGGCCTAACAC 
ATGCAAGTCGAACGGTAACAGGAAGCAGCTTGCTGCTTTGCTGACGAGTG 
GCGGACGGGTGAGTAATGTCTGGGAAACTGCCTGATGGCGGGGGATAACT 
ACTGGAAACGGTAGCTAATACCGCATAACGTCGCAAGACCAAAGAGGGGG 
ACCTTCGGGCCTCTTGCCATCGGATGTGCCCAGATGGGATTAGCTAGTAG 
GTGGGGTAACGGCTCACCTAGGCGACGATCCCTAGCTGGTCTGAGAGGAT 
GACCAGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAG 
CAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGCAGCCATGCCGCG 
TGTATGAAGAAGGCCTTCGGGTTGTAAAGTACTTTCAGCGGGGAGGAAGG 
CGATACGGYTAATAACCGTGTCGATTGACGTTACCCGCAGAAGAAGCACC 
GGCTAACTCCGTGCCAGCAGCCGCGGTA 
 
16C: Pseudomonas marginalis 
TGGAGAGTTTGATCCTGGCTCAGATTGAACGCTGGCGGCAGGCCTAACAC 
ATGCAAGTCGAGCGGTAGAGAGAAGCTTGCTTCTCTTGAGAGCGGCGGAC 
GGGTGAGTAATGCCTAGGAATCTGCCTGGTAGTGGGGGATAACGTTCGGA 
AACGAACGCTAATACCGCATACGTCCTACGGGAGAAAGCAGGGGACCTTC 
GGGCCTTGCGCTATCAGATGAGCCTAGGTCGGATTAGCTAGTTGGTGGGG 
TAATGGCTCACCAAGGCGACGATCCGTAACTGGTCTGAGAGGATGATCAG 
TCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGG 
GGAATATTGGACAATGGGCGAAAGCCTGATCCAGCCATGCCGCGTGTGTG 
AAGAAGGTCTTCGGATTGTAAAGCACTTTAAGTTGGGAGGAAGGGCCATT 
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ACCTAATACGTGATGGTTTTGACGTTACCGACAGAATAAGCACCGGCTAA 
CTCTGTGCCAGCAGCCGCGGTA 
 
17B: Bacillus subtilis – subtilis 
TGGAGAGTTTGATCCTGGCTCAGGACGAACGCTGGCGGCGTGCCTAATAC 
ATGCAAGTCGAGCGGACAGATGGGAGCTTGCTCCCTGATGTTAGCGGCGG 
ACGGGTGAGTAACACGTGGGTAACCTGCCTGTAAGACTGGGATAACTCCG 
GGAAACCGGGGCTAATACCGGATGGTTGTTTGAACCGCATGGTTCAAACA 
TAAAAGGTGGCTTCGGCTACCACTTACAGATGGACCCGCGGCGCATTAGC 
TAGTTGGTGAGGTAACGGCTCACCAAGGCAACGATGCGTAGCCGACCTGA 
GAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGG 
AGGCAGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAAC 
GCCGCGTGAGTGATGAAGGTTTTCGGATCGTAAAGCTCTGTTGTTAGGGA 
AGAACAAGTACCGTTCGAATAGGGCGGTACCTTGACGGTACCTAACCAGA 
AAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTA 
 
 
 
